Trial Profile
Clinico-pathological study on the effectiveness of cepharanthin on the prevention of destruction of acinar structure in Sjogren's syndrome patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Cepharanthine (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 02 Aug 2011 New trial record